Lobbying

Association of Food and Drug Officials's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q4 2022; the issues it reports most are Food Industry (Safety, Labeling, etc.).

Association of Food and Drug Officials

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$90K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Association of Food and Drug Officials lobbying by quarter
Association of Food and Drug Officials lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$30K1
Q2 2025$30K1
Q3 2025$30K1
Q4 2025$30K1
Q1 2026$30K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Food industry$540K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Executive Office of the President (EOP)1 reports

Firms it paid

Firm
Invariant$540K15 quarters

Former officials lobbying for it

Former position
WILLIAM SITTONRep. Scott Franklin: Leg Dir (2023-2025); Policy Adv (2021-2023); Leg Asst, Rep. Francis Rooney (2020-2021); Leg Correspondent, Rep. Chuck Fleischmann (2019-2020); Intern, Rep. Francis Rooney (2019); Intern, Rep. Francis Rooney (2018)Q2 2025
DANIELLE BECKSr. Leg. Asst, Rep. Tom Rooney (2013-2014); Leg. Asst, Rep. Tom Rooney (2012-2013); Leg. Correspondent, Rep. Tom Rooney (2011); Staff Asst, Rep. Tom Rooney (2010); Intern, U.S. Senate Republican Policy CommitteeQ2 2024
KEVIN DIESTELOWIntern, Rep. Elaine Luria (2021)Q3 2023

Lobbying reports

Filed by
07/16for Q2Invariant$30K
04/19for Q1Invariant$30K
01/19for Q4 2025Invariant$30K
25/10/16for Q3 2025Invariant$30K
25/07/16for Q2 2025Invariant$30K
25/07/11for Q1 2025Invariant$30K
25/04/21for Q1 2025Invariant$40K
25/01/20for Q4 2024Invariant$40K
24/10/20for Q3 2024Invariant$40K
24/07/21for Q2 2024Invariant$40K
24/04/21for Q1 2024Invariant$40K
24/01/22for Q4 2023Invariant$40K
23/10/18for Q3 2023Invariant$40K
23/07/17for Q2 2023Invariant$40K
23/04/19for Q1 2023Invariant$40K
23/01/18for Q4 2022Invariant$40K